Innovative cancer research initiatives at Monash University

At the forefront of cancer research, Monash researchers are driving advancements in health and well-being:

Collaborating with the Peter MacCallum Cancer Centre, they have uncovered significant insights into the Hippo signalling pathway, crucial for understanding organ growth and cancer development.
Tim Baker and the Prostate Cancer Research Group are pioneering less toxic treatments for prostate cancer.
The Monash Biomedicine Discovery Institute is using mathematical models to predict effective therapies for breast cancer, addressing treatment resistance.
Dr. Gwo Yaw Ho's team is exploring new treatments for ovarian cancer, focusing on the drug eribulin.
Associate Professor Jeremy Grummet is leading efforts to improve prostate cancer diagnostics and treatment.
Professors Ralf Schittenhelm and Anthony Purcell have discovered how natural killer cells target cancer cells, opening new treatment avenues.
The Victorian Paediatric Cancer Consortium, with Monash's involvement, is advancing childhood cancer research.
Researchers have solved the structure of the LYCHOS protein, a potential drug target for cancer and neurological disorders.